IBEX LTD (IBEX) Stock Fundamental Analysis
USA - NASDAQ:IBEX - BMG4690M1010 - Common Stock
40.94 USD
-1.06 (-2.52%)
40.94 USD
0 (0%)
IBEX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. IBEX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. IBEX is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make IBEX a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
IBEX had positive earnings in the past year.
IBEX had a positive operating cash flow in the past year.
IBEX had positive earnings in each of the past 5 years.
Each year in the past 5 years IBEX had a positive operating cash flow.
1.2 Ratios
IBEX has a better Return On Assets (13.49%) than 93.10% of its industry peers.
IBEX has a Return On Equity of 27.45%. This is amongst the best in the industry. IBEX outperforms 90.80% of its industry peers.
IBEX has a Return On Invested Capital of 20.43%. This is amongst the best in the industry. IBEX outperforms 93.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IBEX's Profit Margin of 6.60% is fine compared to the rest of the industry. IBEX outperforms 70.11% of its industry peers.
IBEX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 8.71%, IBEX is in the better half of the industry, outperforming 64.37% of the companies in the same industry.
In the last couple of years the Operating Margin of IBEX has grown nicely.
IBEX has a Gross Margin (30.91%) which is comparable to the rest of the industry.
IBEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
IBEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 5.42 indicates that IBEX is not in any danger for bankruptcy at the moment.
IBEX has a better Altman-Z score (5.42) than 75.86% of its industry peers.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
The Debt to FCF ratio of IBEX (0.06) is better than 95.40% of its industry peers.
IBEX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, IBEX belongs to the top of the industry, outperforming 83.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.42 |
ROIC/WACC2.16
WACC9.46%
2.3 Liquidity
IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
IBEX's Current ratio of 1.82 is in line compared to the rest of the industry. IBEX outperforms 56.32% of its industry peers.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.82, IBEX is in line with its industry, outperforming 58.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.08% over the past year.
IBEX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.04% yearly.
Looking at the last year, IBEX shows a quite strong growth in Revenue. The Revenue has grown by 9.78% in the last year.
Measured over the past years, IBEX shows a small growth in Revenue. The Revenue has been growing by 6.62% on average per year.
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
3.2 Future
Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.29% on average per year.
IBEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.28% yearly.
EPS Next Y11.65%
EPS Next 2Y11.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 14.62, which indicates a correct valuation of IBEX.
Based on the Price/Earnings ratio, IBEX is valued cheaper than 80.46% of the companies in the same industry.
When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (27.38), we can say IBEX is valued slightly cheaper.
A Price/Forward Earnings ratio of 13.10 indicates a correct valuation of IBEX.
IBEX's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. IBEX is cheaper than 78.16% of the companies in the same industry.
IBEX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.62 | ||
| Fwd PE | 13.1 |
4.2 Price Multiples
86.21% of the companies in the same industry are more expensive than IBEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 70.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.06 | ||
| EV/EBITDA | 8.1 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.25
PEG (5Y)0.36
EPS Next 2Y11.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.94
-1.06 (-2.52%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.1%
Inst Owner Change4.61%
Ins Owners9.07%
Ins Owner Change-3.97%
Market Cap547.37M
Analysts45.71
Price Target39.27 (-4.08%)
Short Float %1.1%
Short Ratio0.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)26.23%
PT rev (3m)26.23%
EPS NQ rev (1m)18.55%
EPS NQ rev (3m)18.55%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)5.66%
Revenue NQ rev (3m)5.66%
Revenue NY rev (1m)4.72%
Revenue NY rev (3m)4.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.62 | ||
| Fwd PE | 13.1 | ||
| P/S | 0.98 | ||
| P/FCF | 20.06 | ||
| P/OCF | 11.99 | ||
| P/B | 4.08 | ||
| P/tB | 4.48 | ||
| EV/EBITDA | 8.1 |
EPS(TTM)2.8
EY6.84%
EPS(NY)3.13
Fwd EY7.64%
FCF(TTM)2.04
FCFY4.99%
OCF(TTM)3.42
OCFY8.34%
SpS41.76
BVpS10.05
TBVpS9.13
PEG (NY)1.25
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.42 |
F-Score8
WACC9.46%
ROIC/WACC2.16
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
EPS Next Y11.65%
EPS Next 2Y11.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year59.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%